[ Pobierz całość w formacie PDF ]
.In their application for human clinical trials, the Sorensen researchers outlined protocols for testing the drug first on healthy subjects, and then on several types of patients: stroke victims, sufferers of Alzheimer's, and persons—like me—in a persistent vegetative state.I can't access the progress reports for those trials: even with patient anonymity, only participating doctors have clearance to examine those records.The animal studies don't shed any light on the increased intelligence in humans.It's reasonable to assume that the effect on intelligence is proportional to the number of neurons replaced by the hormone, which in turn depends on the amount of initial damage.That means that the deep-coma patients would undergo the greatest improvements.Of course, I'd need to see the progress of the other patients to confirm this theory; that'll have to wait.The next question: is there a plateau, or will additional dosages of the hormone cause further increases? I'll know the answer to that sooner than the doctors.* * * *I'm not nervous; in fact, I feel quite relaxed.I'm just lying on my stomach, breathing very slowly.My back is numb; they gave me a local anesthetic, and then injected the hormone K intraspinally.An intravenous wouldn't work, since the hormone can't get past the blood-brain barrier.This is the first such injection I can recall having, though I'm told that I've received two before: the first while still in the coma, the second when I had regained consciousness but no cognitive ability.* * * *More nightmares.They're not all actually violent, but they're the most bizarre, mind-blowing dreams I've ever had, often with nothing in them that I recognize.I often wake up screaming, flailing around in bed.But this time, I know they'll pass.* * * *There are several psychologists at the hospital studying me now.It's interesting to see how they analyze my intelligence.One doctor perceives my skills in terms of components, such as acquisition, retention, performance, and transfer.Another looks at me from the angles of mathematical and logical reasoning, linguistic communication, and spatial visualization.I'm reminded of my college days when I watch these specialists, each with a pet theory, each contorting the evidence to fit.I'm even less convinced by them now than I was back then; they still have nothing to teach me.None of their categorizations are fruitful in analyzing my performance, since—there's no point in denying it—I'm equally good at everything.I could be studying a new class of equation, or the grammar of a foreign language, or the operation of an engine; in each case, everything fits together, all the elements cooperate beautifully.In each case, I don't have to consciously memorize rules, and then apply them mechanically.I just perceive how the system behaves as a whole, as an entity.Of course, I'm aware of all the details and individual steps, but they require so little concentration that they almost feel intuitive.* * * *Penetrating computer security is really quite dull; I can see how it might attract those who can't resist a challenge to their cleverness, but it's not intellectually aesthetic at all.It's no different than tugging on the doors of a locked house until you find an improperly installed lock.A useful activity, but hardly interesting.Getting into the FDA's private database was easy.I played with one of the hospital wall terminals, running the visitor information program, which displays maps and a staff directory.I broke out of the program to the system level, and wrote a decoy program to mimic the opening screen for logging on.Then I simply left the terminal alone; eventually one of my doctors came by to check one of her files.The decoy rejected her password, and then restored the true opening screen.The doctor tried logging on again, and was successful this time, but her password was left with my decoy.Using the doctor's account, I had clearance to view the FDA patient-record database.In the Phase I trials, on healthy volunteers, the hormone had no effect.The ongoing Phase II clinical trials are a different matter.Here are weekly reports on eighty-two patients, each identified by a number, all treated with hormone K, most of them victims of a stroke or Alzheimer's, some of them coma cases.The latest reports confirm my prediction: those with greater brain damage display greater increases in intelligence.PET scans reveal heightened brain metabolism.Why didn't the animal studies provide a precedent for this? I think the concept of critical mass provides an analogy.Animals fall below some critical mass in terms of synapses; their brains support only minimal abstraction, and gain nothing from additional synapses.Humans exceed that critical mass.Their brains support full self-awareness, and—as these records indicate—they use any new synapses to the fullest possible extent.The most exciting records are those of the newly begun investigational studies, using a few of the patients who volunteered.Additional injections of the hormone do increase intelligence further, but again it depends on the degree of initial damage.The patients with minor strokes haven't even reached genius levels.Those with greater damage have gone further.Of the patients originally in deep-coma states, I'm the only one thus far who's received a third injection.I've gained more new synapses than anyone previously studied; it's an open question as to how high my intelligence will go.I can feel my heart pounding when I think about it.* * * *Playing with the doctors is becoming more and more tedious as the weeks go by.They treat me as if I were simply an idiot savant: a patient who exhibits certain signs of high intelligence, but still just a patient.As far as the neurologists are concerned, I'm just a source of PET scan images and an occasional vial of cerebrospinal fluid [ Pobierz całość w formacie PDF ]